Advise patients of the signs and symptoms of potential systemic reactions such as urticaria, periorbital swelling, dyspnea, or hypoxia during and following Mozobil injection, [see ADVERSE REACTIONS]

Patients should inform a health care professional immediately if symptoms of vasovagal reactions such as orthostatic hypotension or syncope occur during or shortly after their Mozobil injection. [see ADVERSE REACTIONS]

If patients experience itching, rash, or reaction at the site of injection, they should notify a health care professional as these symptoms have been treated with over-the-counter medications during clinical trials. [see ADVERSE REACTIONS]

Inform patients that Mozobil (plerixafor injection) may cause gastrointestinal disorders, including diarrhea, nausea, vomiting, flatulence, and abdominal pain. Patients should be told how to manage specific gastrointestinal disorders and to inform their health care professional if severe events occur following Mozobil injection. [see ADVERSE REACTIONS ]

Advise female patients with reproductive potential to use effective contraceptive methods during Mozobil use. [see WARNINGS AND PRECAUTIONS and Use In Specific Populations]

Last reviewed on RxList: 7/13/2010
This monograph has been modified to include the generic and brand name in many instances.